BALYASNY ASSET MANAGEMENT L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager: BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager: Balyasny Asset Management L.P.
Security: Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: LXEO
Shares outstanding: 54,001,211 shares
Disclosed Ownership: 5,394,721 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 06:04:07 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Balyasny Asset Management L.P.	10%	5,394,721	5,394,721	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
BAM GP LLC	10%	5,394,721	5,394,721	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP	10%	5,394,721	5,394,721	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dames GP LLC	10%	5,394,721	5,394,721	/s/ Scott Schroeder	Scott Schroeder / Authorized Signatory
Dmitry Balyasny	10%	5,394,721	5,394,721	/s/ Dmitry Balyasny	Dmitry Balyasny / Self